Most Clicked StoriesMore >


UK study examines timing of transfusions for trauma patients

AABB SmartBrief | Feb 08, 2016

A UK study of 442 trauma patients with massive hemorrhaging found that only 2% received optimal transfusions of high-dose clotting products within an hour of arriving at an emergency department. The findings from the Centre for Trauma Sciences at Queen Mary University of London were reported in the British Journal of Surgery. MedicalResearch.com (02/05)


Survey looks at hospital policies, interventions for blood transfusions

AABB SmartBrief | Feb 11, 2016

HIV-positive organ transplants to be performed at Johns Hopkins

AABB SmartBrief | Feb 09, 2016

Study compares anemia treatments for breast cancer patients

AABB SmartBrief | Feb 10, 2016

AABB posts Association Bulletin on Zika, dengue and chikungunya viruses

AABB SmartBrief | Feb 08, 2016

Hawaii sounds alarm over dengue fever outbreak

AABB SmartBrief | Feb 10, 2016

Trial links tranexamic acid with reduced blood loss during hysterectomy

AABB SmartBrief | Feb 08, 2016

Expectant women need Zika testing after visiting affected areas, CDC says

AABB SmartBrief | Feb 09, 2016

AABB to host Hot Topic audioconference on Feb. 17 on reducing risk of Zika virus

AABB SmartBrief | Feb 09, 2016

Guidance for organ donation aims to prevent Zika transmission

AABB SmartBrief | Feb 09, 2016


Find AABB SmartBrief Issues by Date:



AABB News More >


Reminder: Updated BBTS standards take effect April 1

AABB SmartBrief | Feb 12, 2016

Reminder for early career professionals: experienced colleagues eager to share knowledge

AABB SmartBrief | Feb 11, 2016

AABB partners with U.S. Department of Defense for "Stop the Bleed" campaign

AABB SmartBrief | Feb 10, 2016

AABB to host Hot Topic audioconference on Feb. 17 on reducing risk of Zika virus

AABB SmartBrief | Feb 09, 2016

AABB posts Association Bulletin on Zika, dengue and chikungunya viruses

AABB SmartBrief | Feb 08, 2016




Sign up for AABB SmartBrief



Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Learn more